Investment in TruSpine Technologies

Recently Primorus invested £500,000 in TruSpine Technologies Limited on a pre-new money valuation of £15m.  Founded in December 2014, TruSpine secured intellectual property and subsequently developed the Faci-LOK and Cervi-FAS minimally invasive spine stabilisation devices, and the VOSC Catheter atherosclerosis treatment product ‘VOSC Catheter’. This development is on-going and TruSpine is targeting FDA clearance and commercialisation of its first product, the Faci-LOK with a view to an AIM IPO or trade sale in 2019.